Dysport
News
21.09.2016
Cynosure Receives Approval to Market SculpSure® in South Korea
“MFDS approval of SculpSure is another major step in our international growth strategy for this breakthrough non-invasive fat-reduction treatment,” said Cynosure President and Chief Executive Officer Michael Davin. “As one […]
14.03.2016
Merck Initiates Phase III Study of MSB11022
Merck, a leading science and technology company, today announced the initiation of a global Phase III clinical study of MSB11022, a proposed biosimilar of adalimumab, in chronic plaque psoriasis. This […]
15.01.2019
The PicoStar Laser for Removal of Tattoos, Pigmented Lesions and Permanent Makeup
Tattoos have increased tremendously in popularity – a phenomenon that can be seen across the world. In France alone, the number of tattooists has increased ten-fold within a decade. Twenty […]